Plné znění - 261/2015 Sb.

Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2016

261/2015 Sb.

Sdělení Ministerstva zdravotnictví

INFORMACE

261

SDĚLENÍ

Ministerstva zdravotnictví

ze xxx 22. září 2015

x xxxxxxxxxx složení xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx xxx 2016

 

Xxxxxxxxxxxx xxxxxxxxxxxxx podle §80 xxxx. 1 xxxx. x) zákona x. 258/2000 Xx., x xxxxxxx xxxxxxxxx xxxxxx a x xxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx, stanoví xx xxxxxxx xxxxxxxxxx Xxxxxxx xxxxxxxxxx komise xxxxxxxxx složení xxxxxxxxxx xxxxx pro pravidelná, xxxxxxxx a xxxxxxxxx xxxxxxxx xxx xxx 2016:

1. Xxxxxxxxx složení xxxxxxxxxx xxxxx xxx xxxxxxxxxx xxxxxxxx

1x) xxxxxxxxxxx xxxxxxxx látka proti xxxxxxx, dávivému xxxxx (xxxxxxxxxx forma), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx B, nákazám xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx b (XXxXXxxXXXXXX):

Xxxxxxxxxxx xxxxxxxxxx1 xx xxxx xxx 30 xxxxxxxxxxxxx xxxxxxxx (IU)

Tetani anatoxinum1 xx méně než 40 xxxxxxxxxxxxx xxxxxxxx (XX)

Xxxxxxxx Xxxxxxxxxx xxxxxxxxx:

Xxxxxxxxx xxxxxxxxxx1 25 xxxxxxxxxx

Xxxxxxxxxxxxxxxx xxxxxxxxxxxx1 25 xxxxxxxxxx

Xxxxxxxxxxx1 8 mikrogramů

Antigenum xxxxxxxxx xxxxxxxxxxx X2,3 10 xxxxxxxxxx

Xxxxx xxxxxxxxxxxxx (xxxxxxxxxxxx)

xxxxx 1 (xxxx Xxxxxxx)4 40 X jednotek xxxxxxxx

xxxxx 2 (xxxx XXX-1)4 8 D xxxxxxxx antigenu

typus 3 (xxxx Xxxxxxx)4 32 X xxxxxxxx xxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx xxxxx x xxxxxxxxxxxxxxx 10 xxxxxxxxxx

(xxxxxxxxxxxxxxxxxxx xxxxxxxx)3

xxxxxxxxx cum tetani xxxxxxxxxx xxxx nosným xxxxxxxxx přibližně 25 xxxxxxxxxx

XXXX

1xx) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (acelulárni xxxxx), tetanu, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), virové hepatitidě X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx influenzae xxx x (XXxXXxxXXXXXX)

Xxxxxxxxxxx xxxxxxxxxx xx xxxx než 20 mezinárodních xxxxxxxx (XX)2

Xxxxxx xxxxxxxxxx ne xxxx xxx 40 xxxxxxxxxxxxx xxxxxxxx (IU)2

Antigeny Xxxxxxxxxx xxxxxxxxx

Xxxxxxxxx xxxxxxxxxx 25 xxxxxxxxxx

Xxxxxxxxxxxxxx filamentosum 25 xxxxxxxxxx

Xxxxx Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)3

xxxxx 1 (Mahoney) 40 X jednotek xxxxxxxx4

xxxxx 2 (XXX-1) 8 D xxxxxxxx xxxxxxxx4

xxxxx 3 (Saukett) 32 D xxxxxxxx xxxxxxxx4

Xxxxxxxxx xxxxxxxxx xxxxxxxxxx X5 10 xxxxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx xxxx x xxxxxxxxxxxxxxx 12 xxxxxxxxxx

(Xxxxxxxxxxxxxxxxxxx xxxxxxxx)

xxxxxxxxx xxx xxxxxx xxxxxxxxxx 22-36 xxxxxxxxxx

1x) xxxxxxxx látka xxxxx xxxxxxx, dávivému kašli (xxxxxxxxxx forma), xxxxxx (XXxX):

Xxxxxxxxxxx anatoxinum ≥ 30 xxxxxxxxxxxxx xxxxxxxx

Xxxxxx anatoxinum ≥ 40 mezinárodních jednotek

Pertussis xxxxxxxxxx (XX) 25 xxxxxxxxxx

Xxxxxxxxx haemaglutininum filamentosum (XXX) 25 xxxxxxxxxx

Xxxxxxxxxxx (69xX) 8 xxxxxxxxxx

XXXX

1xx) Xxxxxxxx xxxxx proti xxxxxxx, xxxxxx a xxxxxxxx xxxxx (xxxxxxxxxx)

1 xxxxx (0,5 xx) xxxxxxxx:	Xxxxxxxxx 2 XX* (2 Xx)
Xxxxxxxxxxx xxxxxxxxxx
Xxxxxx xxxxxxxxxx	Xxxxxxxxx 20 IU* (5 Xx)
Xxxxxxxxx antigeny
Pertussis xxxxxxxxxx	2,5 mikrogramu
Haemagglutinum filamentosum	5 xxxxxxxxxx
Xxxxxxxxxxx	3 mikrogramy
Fimbriae, xxxx 2 et 3	5 xxxxxxxxxx
Xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx	1,5 xx (0,33 xx hliníku)

NEBO

1bb) Xxxxxxxx xxxxx xxxxx záškrtu, xxxxxx x xxxxxxxx xxxxx (xxxxxxxxxx komponenta) xx sníženým xxxxxxx xxxxxxxx

Xxxxxxxxxxx anatoxinum1 xx xxxx xxx 2 xxxxxxxxxxx xxxxxxxx (IU) (2,5 Xx)

Xxxxxx xxxxxxxxxx1 xx xxxx než 20 xxxxxxxxxxxxx jednotek (XX) (5 Xx)

Xxxxxxxxxxx xxxxxxxxx xxxxxxxx:

Xxxxxxxxx xxxxxxxxxx1 8 xxxxxxxxxx

Xxxxxxxxx haemagglutinum xxxxxxxxxxxx1

8 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxx1 2,5 xxxxxxxxxx

1 adsorbováno xx xxxxxxxxxxx xxxxxxxx hlinitý (XX(XX)3) 0,3 xxxxxxxxx XX3+ x xxxxxxxxxxx xxxxxxx (XXXX4) 0,2 xxxxxxxxx XX3+

1x) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), xxxxxx, xxxxxxx xxxxxxxxx Hemofilem xxxxxxxxxx x (XXxXXxx):

Xxxxxxxxxxx xxxxxxxxxx	xxx. 30 xxxxxxxxxxxxx jednotek
Tetani xxxxxxxxxx	xxx. 40 xxxxxxxxxxxxx xxxxxxxx
Xxxxxxxxx xxxxxxxxxx (PT)	25 xxxxxxxxxx
Xxxxxxxxx haemaglutininum xxxxxxxxxxxx (XXX)	25 xxxxxxxxxx
Xxxxxxxxxxx (69xX)	8 xxxxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx X	10 xxxxxxxxxx
xxx xxxxxxxxx xxxxxxxx	20-40 xxxxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx typ x:

1 xxxxx xxxxxxxxxxxxx xxxxxxx xxxxxxxx: Xxxxxxxxxxxxxxx Xxx xxxxxxxxxxx (10 xxxxxxxxxx) xxx Xxxxxxxxx xxxxxxxx (25 mikrogramů).

1e) xxxxxxxx látka xxxxx xxxxxx:

Xxxxxx xxxxxxxxxx ... xxx. 40 xxxxxxxxxxxxx xxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidě X xx 16 xxx x xxxx:

Xxxxxxxxx xxxxxxxxx hepatitidis X ... 20 xxxxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:

Xxxxxxxxxxx xxxxx xxxxxxxxxx (Xxxxxxx) min. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx₅₀

Xxxxxxxxxxx xxxxx xxxxxxxxxx (RIT 4385) xxx. 103,7 infekční xxxxx xxx buněčnou xxxxxxx₅₀

Xxxxxxxx xxxxx attenuatum (Xxxxxx RA 27/3) xxx. 103,0 xxxxxxxx xxxxx xxx buněčnou xxxxxxx₅₀

1x) očkovací xxxxx xxxxx xxxxxx xxxxxxxx xxxxx x xxxxxxxxxxxx xxxxx:

Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1 (Xxxxxxx) ... 40 antigenních X xxxxxxxx*

Xxxxx poliomyelitis xxxxxxxxxxx typus 2 (XXX-1) ......... 8 xxxxxxxxxxx X jednotek*

Virus xxxxxxxxxxxxx inactivatum xxxxx 3 (Xxxxxxx) ...... 32 xxxxxxxxxxx D xxxxxxxx*

* xxxx množství xxxxxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxx xxxxxx imunochemické xxxxxx.

1xx) xxxxxxxx xxxxx xxxxx xxxxxxx vyvolaným Xxxxxxxxxxxxx xxxxxxxxxx x xxxxxxxxxxxxxxx xxxxxxx:

Xxxxxxxxxxxxxxx Xxxxxxxxxxxx xxxxxxxxxx xxxxx:

1, 2, 3, 4, 5, 6X, 7F, 8, 9X, 9X, 10X, 11X, 12X, 14, 15X, 17X, 18C, 19X, 19F, 20, 22X, 23X, 33F ... 25 mikrogramů x xxxxxxx sérotypu

1i) xxxxxxxx xxxxx xxxxxxxxxxx xxxxx pneumokokovým xxxxxxxx:

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 1

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 3

Pneumococcale xxxxxxxxxxxxxxx sérotypus 4

Pneumococcale xxxxxxxxxxxxxxx sérotypus 5

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 6X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 6X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 7X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 9V

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 14

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 18X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 23X

1x) xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx forma), xxxxxx, xxxxxx přenosné xxxxx (xxxxxxxxxxxx forma):

Diphtheriae anatoxinum	ne xxxx xxx 2 xxxxxxxxxxx jednotky
Tetani xxxxxxxxxx	xx xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxx xxxxxxxxxx	8 xxxxxxxxxx
Xxxxxxxxx haemagglutinum xxxxxxxxxxxx	8 mikrogramů
Pertaktin	2,5 mikrogramů

Virus xxxxxxxxxxxxxxx inactivatum:

typus 1 (xxxx Xxxxxxx)	40 D xxxxxxxx xxxxxxxx
xxxxx 2 (xxxx XXX-1)	8 X xxxxxxxx antigenu
typus 3 (xxxx Xxxxxxx)	32 X xxxxxxxx xxxxxxxx

XXXX

1xx) očkovací xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):

Xxxxxxxxxx xxxxxx	xxxx xxxx xxxxx 2 mezinárodní xxxxxxxx (2 Lf)
Tetanický xxxxxx	xxxx xxxx rovno 20 xxxxxxxxxxxxx jednotek (5 Xx)

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxx xxxxxx	2,5 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxxxx	5 xxxxxxxxxx
Xxxxxxx xxxx 2+3	5 xxxxxxxxxx
Xxxxxxxxx	3 xxxxxxxxxx

-

Xxxxx xxxxxxxxxxxxx xxxx 1 (xxxxxxxxxxxx)	40 xxxxxxxxxxx X xxxxxxxx
Xxxxx xxxxxxxxxxxxx xxxx 2 (xxxxxxxxxxxx)	8 antigenních D xxxxxxxx
Xxxxx poliomyelitis xxxx 3 (inaktivovaný)	32 antigenních X jednotek

1l) xxxxxxxx xxxxx proti tuberkulóze:

Mycobacterium xxxxx xxxxxxxxxx (BCG) xxxxxxx Xxxxxxx 1331.....0,75 xx

&xx;2,0 x 10⁶ ≤ 8,0 x 10⁶ XXX (xxxxxx xxxxxxx)

1x) očkovací xxxxx xxxxx xxxxxx hepatitidě X xxx osoby xxxxxxxx xx xxxxxxxxxxxx xxxxxxxx:

Xxxxxxxxx tegiminis xxxxxxxxxxx X xxxxxxxxxxxxxx 20 xxxxxxxxxx; xxxxxxxx AS04C xxxxxxxxxx 3-X-xxxxxx-4-xxxxxxxxxxxx-xxxxx X (XXX) 50 xxxxxxxxxx x 1 dávce

1n) Xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx B x xxxxxx xxxxxxx:

Xxxxxxxxx xxxxxxxxx hepatitidis B 10 xxxxxxxxxx v 0,5 ml xxxxxxxx

2. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxx xxxxxxxx

2x) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx X ve formuli xxx xxxxxxx:

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B ... 20 xxxxxxxxxx

2x) xxxxxxxx xxxxx proti xxxxxxxxx

Xxxxx rabiei inactivatum (xxxx Xxxxxx rabies XX/XX 38&xxxx;1503-3X více xxxx xxxxx 2,5 xxxxxxxxxxxxx xxxxxxxx x 1 xxxxx (0,5 xx)

2x) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx X ve xxxxxxx xxx dospělé:

Hepatitis X xxxxx xxxxxxxxxxx

3. Xxxxxxxxx xxxxxxx xxxxxxxxxx látek xxx xxxxxxxxx xxxxxxxx

3x) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidě A xx xxxxxxx xxx xxxxxxx:

Xxxxxxxxx A xxxxx xxxxxxxxxxx

3x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X ve xxxxxxx xxx xxxx:

Xxxxx hepatitis X inactivatum

 

V roce 2016 s xxxxxxx xx plánovanou novelizaci xxxxxxxx č. 537/2006 Sb., o xxxxxxxx proti infekčním xxxxxxx, ve znění xxxxxxxxxx xxxxxxxx, xxxxx xxxxxxxx xxxxxxxxx xxxxxx xxxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro pravidelná xxxxxxxx publikováním xxxxxx xxxxxxxxxxx složení xxxxxx xxxxxxxxxx xxxxx xx Xxxxxx zákonů.

 

Ministr:

v x. XXXx. Policar x. x.

xxxxxxxx xxx xxxxxxxxxxx x právo

Xxxxxxxxx

Xxxxxx xxxxxxx x. 261/2015 Xx. nabyl xxxxxxxxx dnem 24.10.2015.

Xx xxxxx tohoto xxxxxxxx xxxxxxxx xxxx podchyceny xxxxx a doplnění xxxxxxxxxxx xxxxxxx předpisem x.:

131/2016 Sb., xxxxxx xx xxxx sdělení x. 261/2015 Xx., x xxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxxxx, xxxxxxxx a xxxxxxxxx očkování pro xxx 2016

x xxxxxxxxx xx 10.5.2016

Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx jiných xxxxxxxx xxxxxxxx x xxxxxxxx xxxx aktualizováno, xxxxx xx jich xxxxxx derogační xxxxx xxxxx uvedeného právního xxxxxxxx.